Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola Tinari

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Disease Markers|December 19, 2013
Circulating autoantibodies to LGALS3BP: a novel biomarker for cancerAntonino Grassadonia, Nicola Tinari, Clara Natoli, et al.
Journal of Cancer Research and Clinical Oncology|November 19, 2011
Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancerMaurizio Belfiglio, Caterina Fanizza, Nicola Tinari, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 26, 2004
Role of 90K protein in asthma and TH2-type cytokine expressionOmer Kalayci, Esra Birben, Nicola Tinari, et al.
The Journal of Investigative Dermatology|August 8, 2002
Expression of the 90K tumor-associated protein in benign and malignant melanocytic lesionsAnna Maria Cesinaro, Clara Natoli, Antonino Grassadonia, et al.
Medical Hypotheses|November 27, 2012
Tumor-derived microvesicles: the metastasomesReza Ghasemi, Antonino Grassadonia, Nicola Tinari, et al.
Cancer Letters|July 1, 2008
Sunitinib malate (SU-11248) alone or in combination with low-dose docetaxel inhibits the growth of DU-145 prostate cancer xenograftsAlbana Cumashi, Nicola Tinari, Cosmo Rossi, et al.
Cancers|July 15, 2020
The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular PerspectiveDavide Brocco, Rosalba Florio, Laura De Lellis, et al.
Current Cancer Drug Targets|February 8, 2012
An epigenetic approach to pancreatic cancer treatment: the prospective role of histone deacetylase inhibitorsNicola Tinari, Michele De Tursi, Antonino Grassadonia, et al.
International Medical Case Reports Journal|March 28, 2020
Alectinib Induced Regression of Renal and Hepatic Cysts Caused by CrizotinibPietro Di Marino, Gianluca Mannetta, Consiglia Carella, et al.
Journal of Cancer|May 23, 2015
Effect of targeted agents on the endocrine response of breast cancer in the neoadjuvant setting: a systematic reviewAntonino Grassadonia, Marta Caporale, Nicola Tinari, et al.
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Disease Markers|December 19, 2013
Circulating autoantibodies to LGALS3BP: a novel biomarker for cancerAntonino Grassadonia, Nicola Tinari, Clara Natoli, et al.
Journal of Cancer Research and Clinical Oncology|November 19, 2011
Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancerMaurizio Belfiglio, Caterina Fanizza, Nicola Tinari, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 26, 2004
Role of 90K protein in asthma and TH2-type cytokine expressionOmer Kalayci, Esra Birben, Nicola Tinari, et al.
The Journal of Investigative Dermatology|August 8, 2002
Expression of the 90K tumor-associated protein in benign and malignant melanocytic lesionsAnna Maria Cesinaro, Clara Natoli, Antonino Grassadonia, et al.
Medical Hypotheses|November 27, 2012
Tumor-derived microvesicles: the metastasomesReza Ghasemi, Antonino Grassadonia, Nicola Tinari, et al.
Cancer Letters|July 1, 2008
Sunitinib malate (SU-11248) alone or in combination with low-dose docetaxel inhibits the growth of DU-145 prostate cancer xenograftsAlbana Cumashi, Nicola Tinari, Cosmo Rossi, et al.
Cancers|July 15, 2020
The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular PerspectiveDavide Brocco, Rosalba Florio, Laura De Lellis, et al.
Current Cancer Drug Targets|February 8, 2012
An epigenetic approach to pancreatic cancer treatment: the prospective role of histone deacetylase inhibitorsNicola Tinari, Michele De Tursi, Antonino Grassadonia, et al.
International Medical Case Reports Journal|March 28, 2020
Alectinib Induced Regression of Renal and Hepatic Cysts Caused by CrizotinibPietro Di Marino, Gianluca Mannetta, Consiglia Carella, et al.
Journal of Cancer|May 23, 2015
Effect of targeted agents on the endocrine response of breast cancer in the neoadjuvant setting: a systematic reviewAntonino Grassadonia, Marta Caporale, Nicola Tinari, et al.
Pageof 12